Cytokeratin expression in seminoma of the human testis

John C. Cheville, Sudha Rao, Kenneth A. Iczkowski, Christine M. Lohse, V. Shane Pankratz

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

We studied cytokeratin (CK) expression immunohistochemically in 64 seminomas using a panel of commercially available antikeratin antibodies and tested for association of CK expression with patient age, tumor size, stage, and outcome. Seventeen embryonal carcinomas were compared with seminoma. CK7, CAM 5.2, AEI/AEIII, and wide-spectrum screening keratin (WSK) were positive in 41%, 30%, 36%, and 36% of the seminomas, respectively. CK20 and high- molecular-weight keratin (HMWK) were negative in all cases. CD30, placental alkaline phosphatase (PLAP), and epithelial membrane antigen (EMA) were positive in 6%, 100%, and 2% of cases, respectively. There were no differences in patient age, stage, tumor size, or outcome between CK-positive and CK-negative seminomas. CK7, CAM 5.2, AEI/AEIII, and WSK were positive in 100%, 88%, 94%, and 88% of embryonal carcinomas, respective1y, CK20 and HMWK were negative in all cases. CD30, EMA, and PLAP were positive in 100%, 12%, and 76%, respectively. CKs are present in seminoma, and their presence is not associated with a difference in patient age, stage, or outcome. In cases such as small needle biopsy specimens, CK and CD30 stains may be useful in separating seminoma from embryonal carcinoma.

Original languageEnglish (US)
Pages (from-to)583-588
Number of pages6
JournalAmerican Journal of Clinical Pathology
Volume113
Issue number4
StatePublished - 2000

Fingerprint

Seminoma
Keratins
Testis
Embryonal Carcinoma
Mucin-1
Molecular Weight
Needle Biopsy
Neoplasms
Coloring Agents
Antibodies

Keywords

  • CD30
  • Cytokeratin
  • Embryonal carcinoma
  • Outcome
  • Seminoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cheville, J. C., Rao, S., Iczkowski, K. A., Lohse, C. M., & Pankratz, V. S. (2000). Cytokeratin expression in seminoma of the human testis. American Journal of Clinical Pathology, 113(4), 583-588.

Cytokeratin expression in seminoma of the human testis. / Cheville, John C.; Rao, Sudha; Iczkowski, Kenneth A.; Lohse, Christine M.; Pankratz, V. Shane.

In: American Journal of Clinical Pathology, Vol. 113, No. 4, 2000, p. 583-588.

Research output: Contribution to journalArticle

Cheville, JC, Rao, S, Iczkowski, KA, Lohse, CM & Pankratz, VS 2000, 'Cytokeratin expression in seminoma of the human testis', American Journal of Clinical Pathology, vol. 113, no. 4, pp. 583-588.
Cheville JC, Rao S, Iczkowski KA, Lohse CM, Pankratz VS. Cytokeratin expression in seminoma of the human testis. American Journal of Clinical Pathology. 2000;113(4):583-588.
Cheville, John C. ; Rao, Sudha ; Iczkowski, Kenneth A. ; Lohse, Christine M. ; Pankratz, V. Shane. / Cytokeratin expression in seminoma of the human testis. In: American Journal of Clinical Pathology. 2000 ; Vol. 113, No. 4. pp. 583-588.
@article{b78ac1937b3146019d282c55899f9818,
title = "Cytokeratin expression in seminoma of the human testis",
abstract = "We studied cytokeratin (CK) expression immunohistochemically in 64 seminomas using a panel of commercially available antikeratin antibodies and tested for association of CK expression with patient age, tumor size, stage, and outcome. Seventeen embryonal carcinomas were compared with seminoma. CK7, CAM 5.2, AEI/AEIII, and wide-spectrum screening keratin (WSK) were positive in 41{\%}, 30{\%}, 36{\%}, and 36{\%} of the seminomas, respectively. CK20 and high- molecular-weight keratin (HMWK) were negative in all cases. CD30, placental alkaline phosphatase (PLAP), and epithelial membrane antigen (EMA) were positive in 6{\%}, 100{\%}, and 2{\%} of cases, respectively. There were no differences in patient age, stage, tumor size, or outcome between CK-positive and CK-negative seminomas. CK7, CAM 5.2, AEI/AEIII, and WSK were positive in 100{\%}, 88{\%}, 94{\%}, and 88{\%} of embryonal carcinomas, respective1y, CK20 and HMWK were negative in all cases. CD30, EMA, and PLAP were positive in 100{\%}, 12{\%}, and 76{\%}, respectively. CKs are present in seminoma, and their presence is not associated with a difference in patient age, stage, or outcome. In cases such as small needle biopsy specimens, CK and CD30 stains may be useful in separating seminoma from embryonal carcinoma.",
keywords = "CD30, Cytokeratin, Embryonal carcinoma, Outcome, Seminoma",
author = "Cheville, {John C.} and Sudha Rao and Iczkowski, {Kenneth A.} and Lohse, {Christine M.} and Pankratz, {V. Shane}",
year = "2000",
language = "English (US)",
volume = "113",
pages = "583--588",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Cytokeratin expression in seminoma of the human testis

AU - Cheville, John C.

AU - Rao, Sudha

AU - Iczkowski, Kenneth A.

AU - Lohse, Christine M.

AU - Pankratz, V. Shane

PY - 2000

Y1 - 2000

N2 - We studied cytokeratin (CK) expression immunohistochemically in 64 seminomas using a panel of commercially available antikeratin antibodies and tested for association of CK expression with patient age, tumor size, stage, and outcome. Seventeen embryonal carcinomas were compared with seminoma. CK7, CAM 5.2, AEI/AEIII, and wide-spectrum screening keratin (WSK) were positive in 41%, 30%, 36%, and 36% of the seminomas, respectively. CK20 and high- molecular-weight keratin (HMWK) were negative in all cases. CD30, placental alkaline phosphatase (PLAP), and epithelial membrane antigen (EMA) were positive in 6%, 100%, and 2% of cases, respectively. There were no differences in patient age, stage, tumor size, or outcome between CK-positive and CK-negative seminomas. CK7, CAM 5.2, AEI/AEIII, and WSK were positive in 100%, 88%, 94%, and 88% of embryonal carcinomas, respective1y, CK20 and HMWK were negative in all cases. CD30, EMA, and PLAP were positive in 100%, 12%, and 76%, respectively. CKs are present in seminoma, and their presence is not associated with a difference in patient age, stage, or outcome. In cases such as small needle biopsy specimens, CK and CD30 stains may be useful in separating seminoma from embryonal carcinoma.

AB - We studied cytokeratin (CK) expression immunohistochemically in 64 seminomas using a panel of commercially available antikeratin antibodies and tested for association of CK expression with patient age, tumor size, stage, and outcome. Seventeen embryonal carcinomas were compared with seminoma. CK7, CAM 5.2, AEI/AEIII, and wide-spectrum screening keratin (WSK) were positive in 41%, 30%, 36%, and 36% of the seminomas, respectively. CK20 and high- molecular-weight keratin (HMWK) were negative in all cases. CD30, placental alkaline phosphatase (PLAP), and epithelial membrane antigen (EMA) were positive in 6%, 100%, and 2% of cases, respectively. There were no differences in patient age, stage, tumor size, or outcome between CK-positive and CK-negative seminomas. CK7, CAM 5.2, AEI/AEIII, and WSK were positive in 100%, 88%, 94%, and 88% of embryonal carcinomas, respective1y, CK20 and HMWK were negative in all cases. CD30, EMA, and PLAP were positive in 100%, 12%, and 76%, respectively. CKs are present in seminoma, and their presence is not associated with a difference in patient age, stage, or outcome. In cases such as small needle biopsy specimens, CK and CD30 stains may be useful in separating seminoma from embryonal carcinoma.

KW - CD30

KW - Cytokeratin

KW - Embryonal carcinoma

KW - Outcome

KW - Seminoma

UR - http://www.scopus.com/inward/record.url?scp=0034093274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034093274&partnerID=8YFLogxK

M3 - Article

VL - 113

SP - 583

EP - 588

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -